Literature DB >> 17009070

Ventricular tachycardia induced by abuse of ephedrine in a young healthy woman.

Peter Rakovec1, Matija Kozak, Miran Sebestjen.   

Abstract

INTRODUCTION: Ephedrine or ephedra herbal products have occasionally been used to enhance sports performance and energy or to aid weight loss. The most serious side effects are those on cardiovascular function, including acute myocardial infarction, severe hypertension, myocarditis and lethal cardiac arrhythmias. CASE REPORT: A 19-year-old woman was taking ephedrine to enhance her sports performance. After 10 days of this medication she developed hemodynamically unstable ventricular tachycardia resistant to cardioversion and amiodarone treatment. She converted to sinus rhythm 60 hours later, presumably when the plasma ephedrine level had sufficiently decreased. In an electrophysiological study the ventricular tachycardia could be induced and successfully ablated. There were no recurrences during follow-up of more than a year. The use of ephedrine carries a risk of development of life-threatening arrhythmias. DISCUSSION: Ephedrine alone cannot be considered as the ultimate cause of tachycardia in our patient; however, it is highly probable that ephedrine triggered the tachycardic attack. The proarrhythmic effect most likely occurred because of underlying idiopathic left ventricular tachycardia. Although the patient could have developed her first attack of ventricular tachycardia at any time in her life, it is highly improbable that the attack following the ephedrine abuse was purely coincidental.
CONCLUSION: Our experience with the reported patient shows that ephedrine alone, or in combination with substances that increase its effects on the cardiovascular system, may also trigger paroxysms of non-ischemic ventricular tachycardia. The use of ephedrine carries a risk of development of life-threatening arrhythmias and should be discouraged.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009070     DOI: 10.1007/s00508-006-0655-5

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  15 in total

1.  Fascicular tachycardia: uncommon or just unrecognised?

Authors:  C A Eynon; L Howe; S Firoozan
Journal:  Emerg Med J       Date:  2002-09       Impact factor: 2.740

2.  Ephedra ban: no shortage of reasons.

Authors:  Carol Rados
Journal:  FDA Consum       Date:  2004 Mar-Apr

Review 3.  Contamination of dietary supplements and positive drug tests in sport.

Authors:  R J Maughan
Journal:  J Sports Sci       Date:  2005-09       Impact factor: 3.337

Review 4.  Clinical pharmacology of caffeine.

Authors:  N L Benowitz
Journal:  Annu Rev Med       Date:  1990       Impact factor: 13.739

5.  Coronary artery spasm and myocardial infarction in a patient with normal coronary arteries: temporal relationship to pseudoephedrine ingestion.

Authors:  I Wiener; A G Tilkian; M Palazzolo
Journal:  Cathet Cardiovasc Diagn       Date:  1990-05

Review 6.  Arrhythmogenic effects of illicit drugs in athletes.

Authors:  Francesco Furlanello; Stefano Bentivegna; Riccardo Cappato; Luigi De Ambroggi
Journal:  Ital Heart J       Date:  2003-12

7.  Effects of caffeine on plasma renin activity, catecholamines and blood pressure.

Authors:  D Robertson; J C Frölich; R K Carr; J T Watson; J W Hollifield; D G Shand; J A Oates
Journal:  N Engl J Med       Date:  1978-01-26       Impact factor: 91.245

8.  Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.

Authors:  C A Haller; N L Benowitz
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 176.079

9.  Idiopathic fascicular ventricular tachycardia.

Authors:  Johnson Francis; K Venugopal; S A Khadar; N Sudhayakumar; Anoop K Gupta
Journal:  Indian Pacing Electrophysiol J       Date:  2004-07-01

10.  Acute poisoning with autumn crocus (Colchicum autumnale L.).

Authors:  Miran Brvar; Gordana Kozelj; Martin Mozina; Matjaz Bunc
Journal:  Wien Klin Wochenschr       Date:  2004-03-31       Impact factor: 2.275

View more
  2 in total

1.  cAMP Response Element Binding Protein Expression in the Hippocampus of Rhesus Macaques with Chronic Ephedrine Addiction.

Authors:  Zongbo Sun; Ye Ma; Shouxing Duan; Lei Xie; Junyao Lv; Jinzhuang Huang; Zhirong Lin; Ruiwei Guo; Shuhua Ma
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

2.  Methylephedrine-induced heart failure in a habitual user of paediatric cough syrup: a case report.

Authors:  Moeko Suzuki; Haruhiko Higashi; Shuntaro Ikeda; Osamu Yamaguchi
Journal:  Eur Heart J Case Rep       Date:  2020-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.